VIDEO: Connie Lehman discusses trends in breast imaging

"Mammography is clearly the the best tool we have to detect breast cancer early when it can be cured, but it does have its limitations in very dense breast tissue," Lehman said. "Clearly the advances in digital mammography have improved our ability to penetrate dense breast tissue."

She said this was clear in clinical trials comparing full field digital mammography (FFDM) to film mammography. This has been further improved by the advance of digital breast tomosynthesis (DBT), which shoots a series of images that are reconstructed into slices, so radiologists can look between the layers that are hard to see through when they are stacked

"We are excited about 3D tomosynthesis, where we can do thin slices through breast tissue to uncover these cancers that hide in those dense, dense areas of the breast," she explained. 

The U.S. Food and Drug Administration (FDA) reports that nearly 50% of mammography systems are now tomosynthesis, and each year that number grows. Lehman said 3D mammography is rapidly becoming the standard-of-care. However, she said there are still concerns about the higher cost of these new systems.

"If you had a community that was really having challenges in resources, would you rather screen twice as many women with 2D mammography, or screen half as many women with 3D?" She said. 

Lehman is also excited about advances in vascular imaging, which includes breast MRI and contrast-enhanced mammography (CEM). "This allows us to see areas that are recruiting blood vessels as the cancer cells and the tumors grow," she said. 

Other technologies to watch include the use of artificial intelligence (AI), which is being used to help better assess breast density and with sorting through large numbers of breast images in DBT datasets. 

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup